Sistema de Información Esencial en Terapéutica y Salud


Última actualización: 24/5/2020
SIETES contiene 93008 citas

 1 a 20 de 61 siguiente >>
Presentar resultados
Seleccionar todas
1. Cita con resumen
2. Cita con resumen
Anónimo. FDA announces list of off-patent drugs with no competition. DIA Daily 2017:1. [Ref.ID 101658]
3. Cita con resumen
Alpern JD, Song J, Stauffer WM. Essential medicines in the United States - Why access is diminishing. N Engl J Med 2016;374:1904-7. [Ref.ID 100324]
4.Enlace a cita originalTiene citas relacionadas Cita con resumen
Savioli L. Preventive anthelmintic chemotherapy — expanding the armamentarium. N Engl J Med 2014;370:665-6. [Ref.ID 97118]
5.Tiene citas relacionadas Cita con resumen
Speich B, Ame SM, Ali SM, Alles R, Huwyler J, Hattendorf J, Utzinger J, Albonico M, Keiser J. Oxantel pamoate–albendazole for trichuris trichiura Infection. N Engl J Med 2014;370:610-20. [Ref.ID 97114]
6. Cita con resumen
Swanson SJ, Phares CR, Mamo B, Smith KE, Cetron MS, Stauffer WM. Albendazole therapy and enteric parasites iin United States - Bound refugees. N Engl J Med 2012;366:1498-507. [Ref.ID 92767]
7.Enlace a cita original
Abdel-tawab AM, Bradley M, Ghazaly EA, Horton J, El-Setouhy M. Albendazole and its metabolites in the breast milk of lactating women following a single oral dose of albendazole. Br J Clin Pharmacol 2009;68:737-42. [Ref.ID 87163]
8. Cita con resumen
Bockarie M, Molyneux D. The end of lymphatic filariasis?. BMJ 2009;338:1470-2. [Ref.ID 86083]
9. Cita con resumen
Hochberg AM, Pearson RK, O'Hara DJ, Reisinger SJ. Drug-versus-drug adverse event rate comparisons: a pilot study based on data from the US FDA Adverse Event Reporting System. Drug Saf 2009;32:137-46. [Ref.ID 85482]
10. Cita con resumen
Molyneux DH. 10 years of success in addressing lymphatic filariasis. Lancet 2009;373:529-30. [Ref.ID 85275]
11. Cita con resumen
Reddy M, Gill SS, Kalkar SR, Wu W, Anderson PJ, Rochon PA. Oral drug therapy for multiple neglected tropical diseases. A systematic review. JAMA 2007;298:1911-24. [Ref.ID 81465]
12. Cita con resumen
Anónimo. Merck KGaA donates praziquantel for tropical disease. Scrip 2007;3253:17. [Ref.ID 79886]
Specht S, Hoerauf A. Does helminth elimination promote or prevent malaria?. Lancet 2007;369:446-7. [Ref.ID 79169]
14. Cita con resumen
Campbell OMR, Graham WJ, on behalf of The Lancet Maternal Survival Series steering group. Strategies for reducing maternal mortality: getting on with what works. Lancet 2006;368:1284-99. [Ref.ID 78143]
Del Brutto OH, Roos KL, Coffey CS, García HH. Meta-analysis: cysticidal drugs for neurocysticercosis: albendazole and praziquantel. Ann Intern Med 2006;145:43-51. [Ref.ID 77576]
17.Tiene citas relacionadas Cita con resumen
Cooper PJ, Chico ME, Vaca MG, Moncayo A-L, Bland JM, Mafla E, Sánchez F, Rodrigues LC, Strachan DP, Griffin GE. Effect of albendazole treatments on the prevalence of atopy in children living in communities endemic for geohelminth parasites: a cluster-randomised trial. Lancet 2006;367:1598-603. [Ref.ID 76881]
18. Cita con resumen
Chirac P, Torreele E. Global framework on essential health R&D. Lancet 2006;367:1560-1. [Ref.ID 76873]
19.Tiene citas relacionadas Cita con resumen
Lau S, Matricardi PM. Worms, asthma, and the hygiene hypothesis. Lancet 2006;367:1556-8. [Ref.ID 76872]
20.Tiene citas relacionadas Cita con resumen
Ramzy RMR, El Setouhy M, Helmy H, Ahmed ES, Elaziz KMA, Farid HA, Shannon WD, Weil GJ. Effect of yearly mass drug administration with diethylcarbamazepine and albendazole on bancroftian filariasis in Egypt: a comprehensive assessment. Lancet 2006;367:992-9. [Ref.ID 76451]
Seleccionar todas
 1 a 20 de 61 siguiente >>